
Translational Neurometrics provides preclinical neuroscience research to help drug developers validate targets and assess brain effects. They use in vivo neurotechnology, neuronal recordings, neural decoding with AI, and techniques like optogenetics and pharmacogenetics to measure drug impact across species. The company operates as a contract research organization serving pharmaceutical and biotech customers. Key technologies include electrophysiology, silicon probes, gene transfer, and AI-driven data analysis with rigorous blind study designs. Their work yields pharmacodynamic insights and actionable results for neuropsychiatric drug development.

Translational Neurometrics provides preclinical neuroscience research to help drug developers validate targets and assess brain effects. They use in vivo neurotechnology, neuronal recordings, neural decoding with AI, and techniques like optogenetics and pharmacogenetics to measure drug impact across species. The company operates as a contract research organization serving pharmaceutical and biotech customers. Key technologies include electrophysiology, silicon probes, gene transfer, and AI-driven data analysis with rigorous blind study designs. Their work yields pharmacodynamic insights and actionable results for neuropsychiatric drug development.